From a tech perspective this is now so oversold, RSI on its knees, i have been buying happily and will again no doubt today, very easy money. Look at the two year chart and see what it did after a sell off like this
I completely agree - however what it shows is if they can prove themselves once in north sea and continuing need to produce....then opportunity comes knocking - risk/reward
“ At a commercial level, the Group's arrangements with Azerion continue to be operated on a 'business as usual' basis by both parties, with October already the highest grossing month to date and with November and December anticipated to grow further month on month.”
it was shell that peaked my interest to with the drill going ahead. I was wondering if we would see a tr1 or anything from sneller but maybe as you say they liked what they saw on seismic
After seismic data the chances went from 20% to 55% on success. Shell is leading this on. So different to other aim small oilers. I first purchased at 3.35. Waited and took 2.75 and 2.77 this morning. Placing was done at 3.5. So felt comfortable doing this as I can derisk slightly before end of January when I expect this to be back above placing price and then ride the rest in to results.
The share price flys tomorrow. Those warrants have been forward sold. It was clear there was some rumour going round to about possible negative rns and mms milked it. Further shorts to close now (squeeze). This flys now
This is a grey area fyi....it is better put it like this "At the time of buying the director knew of no price sensitive information".....tender bids wise are usually closed process so nothing to say a tender win can not land tomorrow etc.
I have seen many times on stock marker where news lands after director buys and that's within a week of them
I have asked the company what his holding is.......as per c4xd webpage on investors he is apparently over 23% again despite no new tr1.....if he did partake in last placing at 25....selling down here may not be to clever.
On the milestones - if you look again on the webpage you can see how close it is to going clinical trial so further milestones maybe due very soon. Cash wise i think close to 20m currently and assets close to 20, so current mcap of only 57m is quite low.
once that is clear it moves back up.....will keep scaling in, i noted the reaction on share price on last bit of news drop before a nice rise over a week or so